AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34935176 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-vegetarian high-fat diet
Number of subjects: 65
Study 33043474 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 375
Study 33043474 — intervention group
Group type: EXPERIMENTAL
Intervention: ZAAD
Number of subjects: 375
Study 35618101 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 Gy radiotherapy
Number of subjects: 686
Study 35618101 — intervention group
Group type: COMPARATOR
Intervention: 20 Gy in 5 fractions
Number of subjects: 686
Study 35618101 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 686
Study 33610419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-processed food (UPF) consumption
Number of subjects: 1485
Study 32371038 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional compression factor (CCF) group (compression factor = 0.75 D)
Number of subjects: 50
Study 32371038 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased compression factor (ICF) group (extra 1.00D)
Number of subjects: 50
Study 32371038 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study 34939897 — intervention group
Group type: COMPARATOR
Intervention: 6-month persistent infection (6MPI)
Number of subjects: 3025
Study 34939897 — intervention group
Group type: COMPARATOR
Intervention: Oncogenic HPV types
Number of subjects: 3025
Study 34731640 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically-assisted vaginal hysterectomy (LAVH)
Number of subjects: 227
Study 34731640 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 227
Study 33802012 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB complex (2.4 g of HMB + 14 g of glutamine + 14 g of arginine)
Number of subjects: 49
Study 33802012 — intervention group
Group type: COMPARATOR
Intervention: Control group (glutamine complex, 7.2 g of protein including 6 g of glutamine)
Number of subjects: 49
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: weighted genetic risk score (wGRS)
Number of subjects: 633
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis using SNP rs1165196
Number of subjects: 633
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis using wGRS
Number of subjects: 633
Study 37650921 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (1 g) with piperine (5 mg) twice daily
Number of subjects: 200
Study 37650921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 33498854 — intervention group
Group type: EXPERIMENTAL
Intervention: Full prognostic index
Number of subjects: 7042
Study 33498854 — intervention group
Group type: COMPARATOR
Intervention: Simplified risk score at diagnosis
Number of subjects: 7042
Study 32112718 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 80
Study 32112718 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating microsaw
Number of subjects: 80
Study 32112718 — intervention group
Group type: COMPARATOR
Intervention: Conventional burrs
Number of subjects: 80
Study 34374430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography decision aid (DA)
Number of subjects: 283
Study 32235946 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized group vestibular rehabilitation (1 h 30 min, once a week, supervised)
Number of subjects: 58
Study 32235946 — intervention group
Group type: COMPARATOR
Intervention: Cawthorne‐Cooksey exercises and simple balance exercises (15 min, twice a day, unsupervised)
Number of subjects: 58
Study 36732096 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound score (LUSsc)
Number of subjects: 857
Study 36732096 — intervention group
Group type: EXPERIMENTAL
Intervention: LUSsc cut-off point of 8 for <32+0 weeks group
Number of subjects: 857
Study 36732096 — intervention group
Group type: EXPERIMENTAL
Intervention: LUSsc cut-off point of 7 for 32+0‐36+6 weeks group
Number of subjects: 857
Study 36732096 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation results for <32+0 weeks group
Number of subjects: 857
Study 36732096 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation results for 32+0‐36+6 weeks group
Number of subjects: 857
Study 34477816 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P10
Number of subjects: 140
Study 34477816 — intervention group
Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 140
Study 35309222 — intervention group
Group type: EXPERIMENTAL
Intervention: CDIO training model
Number of subjects: 38
Study 35309222 — intervention group
Group type: COMPARATOR
Intervention: Traditional training method
Number of subjects: 38
Study 33866270 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: TV 6 ml/kg, PEEP 5 cmH20
Number of subjects: 25
Study 33866270 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: TV 6 ml/kg, PEEP 8 cmH20
Number of subjects: 25
Study 33866270 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: TV 8 ml/kg, PEEP 5 cmH20
Number of subjects: 25
Study 33866270 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D: TV 8 ml/kg, PEEP 8 cmH20
Number of subjects: 25
Study 32690492 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted hatching (AH) on warmed blastocysts before embryo transfer
Number of subjects: 0
Study 32690492 — intervention group
Group type: COMPARATOR
Intervention: Control group (no assisted hatching)
Number of subjects: 0
Study 32690492 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 0
Study 35022661 — intervention group
Group type: EXPERIMENTAL
Intervention: Group- plus home-based Tai Chi program
Number of subjects: 98
Study 35022661 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 98
Study 34760067 — intervention group
Group type: EXPERIMENTAL
Intervention: Kedo-SG blue pediatric rotary files
Number of subjects: 45
Study 34760067 — intervention group
Group type: EXPERIMENTAL
Intervention: Kedo-SH pediatric hand files
Number of subjects: 45
Study 34760067 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating hand K-files
Number of subjects: 45
Study 34760067 — intervention group
Group type: COMPARATOR
Intervention: All groups (Kedo-SG blue, Kedo-SH, reciprocating hand K-files)
Number of subjects: 45
Study 33141834 — intervention group
Group type: EXPERIMENTAL
Intervention: Literacy-sensitive action plan
Number of subjects: 1769
Study 33141834 — intervention group
Group type: COMPARATOR
Intervention: Standard action plan
Number of subjects: 1769
Study 33141834 — intervention group
Group type: COMPARATOR
Intervention: Allocation method (random, health literacy screening, participant selection)
Number of subjects: 1769
Study 33949001 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐ATG 2.5 mg/kg
Number of subjects: 81
Study 33949001 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐ATG 3.5 mg/kg
Number of subjects: 81
Study 33949001 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher r‐ATG concentration (day 14)
Number of subjects: 81
Study 33949001 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher r‐ATG concentration (day 28)
Number of subjects: 81
Study 33949001 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher r‐ATG concentrations at day 28
Number of subjects: 81
Study 35033547 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific balance training
Number of subjects: 40
Study 35033547 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive balance training
Number of subjects: 40
Study 35033547 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 33284903 — intervention group
Group type: COMPARATOR
Intervention: 0.5% sodium hypochlorite (positive control)
Number of subjects: 28
Study 33284903 — intervention group
Group type: EXPERIMENTAL
Intervention: Dettol liquid soap
Number of subjects: 28
Study 33284903 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifebuoy liquid soap
Number of subjects: 28
Study 33284903 — intervention group
Group type: COMPARATOR
Intervention: Phosphate-buffered saline solution (negative control)
Number of subjects: 28
Study 36412376 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training (VRT) for 30 min in seated position using Xbox-Kinect, 3 days/week for 4 weeks
Number of subjects: 21
Study 36412376 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy for 30 min, 3 days/week for 4 weeks
Number of subjects: 21
Study 32008198 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch (RS) supplementation (16 g RS/day)
Number of subjects: 16
Study 33550845 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary Team (MDT) approach
Number of subjects: 490
Study 33550845 — intervention group
Group type: COMPARATOR
Intervention: Traditional screening approach
Number of subjects: 490
Study 35459118 — intervention group
Group type: EXPERIMENTAL
Intervention: PEERS® (n = 54)
Number of subjects: 106
Study 35459118 — intervention group
Group type: COMPARATOR
Intervention: ROAD (n = 52)
Number of subjects: 106
Study 32313980 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg)
Number of subjects: 23
Study 32313980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.150 mg)
Number of subjects: 23
Study 32313980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 35948873 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH intervention (text message‐delivered self‐management support focusing on medication adherence, diet, and exercise)
Number of subjects: 506
Study 33276298 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic use in neonatal lambs
Number of subjects: 133
Study 32151119 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral/enteral nutrition plus pantoprazole
Number of subjects: 300
Study 32151119 — intervention group
Group type: COMPARATOR
Intervention: Oral/enteral nutrition only
Number of subjects: 300
Study 35460853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided SFA puncture (p-group)
Number of subjects: 107
Study 35460853 — intervention group
Group type: COMPARATOR
Intervention: Traditional SFA cutdown (c-group)
Number of subjects: 107
Study 35460853 — intervention group
Group type: COMPARATOR
Intervention: Comparison of time management for vascular access
Number of subjects: 107
Study 35460853 — intervention group
Group type: COMPARATOR
Intervention: Anesthesia administered
Number of subjects: 107
Study 35460853 — intervention group
Group type: COMPARATOR
Intervention: Complications within 3 months
Number of subjects: 107
Study 32522414 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1‐mL ID injection of purified Vero cell rabies vaccine (PVRV) on days 0 and 28
Number of subjects: 49
Study 32522414 — intervention group
Group type: COMPARATOR
Intervention: 0.5‐mL intramuscular PVRV on D0, D7 and D28
Number of subjects: 49
Study 32522414 — intervention group
Group type: EXPERIMENTAL
Intervention: JE‐CV subcutaneously on D0 and D365
Number of subjects: 49
Study 36184275 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) infusion following hysteroscopic adhesiolysis
Number of subjects: 123
Study 36184275 — intervention group
Group type: COMPARATOR
Intervention: Control group (only intrauterine-suitable balloon)
Number of subjects: 123
Study 34579104 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of EGCG and 60 mL of coconut oil
Number of subjects: 51
Study 34579104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 32001194 — intervention group
Group type: EXPERIMENTAL
Intervention: MERS-CoV outbreak impact on psychological distress
Number of subjects: 200
Study 32001194 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived sufficiency of information
Number of subjects: 200
Study 32001194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of information
Number of subjects: 200
Study 32001194 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported hygienic habits and social avoidance
Number of subjects: 200
Study 32001194 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessed resources
Number of subjects: 200
Study 32996349 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine practice pattern)
Number of subjects: 164
Study 33028555 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline and nicotine replacement therapy (NRT) lozenges
Number of subjects: 0
Study 33028555 — intervention group
Group type: COMPARATOR
Intervention: Varenicline and placebo lozenges
Number of subjects: 0
Study 35254390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive SBP target less than 120 mm Hg
Number of subjects: 547
Study 35254390 — intervention group
Group type: COMPARATOR
Intervention: Standard SBP target less than 140 mm Hg
Number of subjects: 547
Study 35254390 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group comparison
Number of subjects: 547
Study 34135056 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative wound irrigation with aqueous 10% povidone–iodine solution (40 mL for 1 min before skin suture)
Number of subjects: 950
Study 34135056 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (100 mL for 1 min before skin suture)
Number of subjects: 950
Study 32134735 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum zinc concentration measurement
Number of subjects: 3500
Study 32134735 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc deficiency defined as serum zinc level < 75 μg/dL
Number of subjects: 3500
Study 32134735 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-sex specific reference percentile values for serum zinc
Number of subjects: 3500
Study 33215197 — intervention group
Group type: EXPERIMENTAL
Intervention: Household contacts diagnosed with TB (cases)
Number of subjects: 1254
Study 33215197 — intervention group
Group type: COMPARATOR
Intervention: Household contacts without TB diagnosis (controls)
Number of subjects: 1254
Study 32081593 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity Laser Therapy (LILT) applied on the experimental side on the 1st, 3rd, 5th, 7th, 14th and 15th days consecutively.
Number of subjects: 10
Study 32081593 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity Laser Therapy (LILT) at the end of canine retraction (4.5 months).
Number of subjects: 10
Study 32081593 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 10
Study 34326995 — intervention group
Group type: EXPERIMENTAL
Intervention: Community engagement (CE) activities with home-based sessions and village meetings
Number of subjects: 46614
Study 34326995 — intervention group
Group type: COMPARATOR
Intervention: Control clusters (no community engagement activities)
Number of subjects: 46614
Study 33225978 — intervention group
Group type: EXPERIMENTAL
Intervention: Shamiri group intervention
Number of subjects: 420
Study 33225978 — intervention group
Group type: COMPARATOR
Intervention: Study-skills control intervention
Number of subjects: 420
Study 36247106 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly group singing for 12 weeks
Number of subjects: 32
Study 36247106 — intervention group
Group type: COMPARATOR
Intervention: Facilitated discussion group for 12 weeks
Number of subjects: 32
Study 32049124 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian hierarchical model
Number of subjects: 1758145
Study 35012462 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN) 5 mg daily for 4 days
Number of subjects: 297
Study 35012462 — intervention group
Group type: COMPARATOR
Intervention: Sham patch
Number of subjects: 297
Study 34010275 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted position with BFR
Number of subjects: 13
Study 34010275 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted position without BFR
Number of subjects: 13
Study 34010275 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright position with BFR
Number of subjects: 13
Study 34010275 — intervention group
Group type: COMPARATOR
Intervention: Upright position without BFR
Number of subjects: 13
Study 34010275 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 13
Study 32998005 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers (high-dose, medium-dose, low-dose)
Number of subjects: 6690
Study 32998005 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose β-blockers
Number of subjects: 6690
Study 32998005 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasodilating β-blockers
Number of subjects: 6690
Study 33944672 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal urine metabolomic analysis using mass spectrometry and nuclear magnetic resonance spectrometry
Number of subjects: 36
Study 33944672 — intervention group
Group type: COMPARATOR
Intervention: Maternal urine metabolomic analysis
Number of subjects: 36
Study 32740976 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental attention remediation treatment
Number of subjects: 49
Study 32740976 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 49
Study 34694201 — intervention group
Group type: EXPERIMENTAL
Intervention: Duolingo (Spanish learning app)
Number of subjects: 76
Study 34694201 — intervention group
Group type: EXPERIMENTAL
Intervention: BrainHQ (brain training app)
Number of subjects: 76
Study 34694201 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 76
Study 33006904 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitors (rtCGMs)
Number of subjects: 0
Study 33006904 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 0
Study 32483147 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei CBA L74-fermented formula
Number of subjects: 13
Study 32483147 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 13
Study 32483147 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding (reference group)
Number of subjects: 13
Study 35331535 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea infusion with standardized breakfast
Number of subjects: 21
Study 35331535 — intervention group
Group type: COMPARATOR
Intervention: Water with standardized breakfast
Number of subjects: 21
Study 32696033 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of benzathine penicillin G
Number of subjects: 15
Study 32696033 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular administration of benzathine penicillin G
Number of subjects: 15
Study 33453467 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR by foot
Number of subjects: 65
Study 33453467 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR (hands)
Number of subjects: 65
Study 32423151 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle brace (AB)
Number of subjects: 33
Study 32423151 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT)
Number of subjects: 33
Study 32423151 — intervention group
Group type: COMPARATOR
Intervention: Control (Cn)
Number of subjects: 33
Study 33523368 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of 123 miRNAs classified into 63 families; stem-loop hairpin structures predicted.
Number of subjects: 0
Study 33523368 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem-loop qRT-PCR for 25 randomly selected ain-miRNAs.
Number of subjects: 0
Study 33320051 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUCOSE+FRUCTOSE
Number of subjects: 9
Study 33320051 — intervention group
Group type: COMPARATOR
Intervention: GLUCOSE ONLY
Number of subjects: 9
Study 33417340 — intervention group
Group type: EXPERIMENTAL
Intervention: New carotid plaque
Number of subjects: 47
Study 33417340 — intervention group
Group type: COMPARATOR
Intervention: CIMT progression
Number of subjects: 47
Study 32023582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting triglycerides
Number of subjects: 4988
Study 32023582 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fasting triglycerides
Number of subjects: 4988
Study 35368032 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal professional breastfeeding education for the family
Number of subjects: 342
Study 35368032 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prenatal professional breastfeeding education)
Number of subjects: 342
Study 34601832 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health augmented cardiac rehabilitation (MCard) including counselling, brief text messages, and standard post-ACS care
Number of subjects: 160
Study 34601832 — intervention group
Group type: COMPARATOR
Intervention: Standard post-ACS care (control group)
Number of subjects: 160
Study 34081196 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOAC) treatment prior to lockdown
Number of subjects: 8
Study 34081196 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOAC) treatment during lockdown
Number of subjects: 8
Study 33840403 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 46
Study 33840403 — intervention group
Group type: COMPARATOR
Intervention: Umbilical cord milking (UCM)
Number of subjects: 46
Study 33419858 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care (EPC)
Number of subjects: 461
Study 33350619 — intervention group
Group type: EXPERIMENTAL
Intervention: 30° left‐lateral tilt position
Number of subjects: 75
Study 33350619 — intervention group
Group type: COMPARATOR
Intervention: 15° left‐lateral tilt position
Number of subjects: 75
Study 33350619 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 75
Study 32060497 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet + extra-virgin olive oil
Number of subjects: 889
Study 32060497 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet + nuts
Number of subjects: 889
Study 32060497 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 889
Study 32060497 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted score of metabolites
Number of subjects: 889
Study 32060497 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline circulating concentrations of metabolites (hexose monophosphate, pyruvate, lactate, alanine, glycerol-3 phosphate, isocitrate)
Number of subjects: 889
Study 32060497 — intervention group
Group type: EXPERIMENTAL
Intervention: One-year increases in metabolites
Number of subjects: 889
Study 36349675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Handicap Inventory‐China scale in exploration group (n = 565)
Number of subjects: 1129